Summary
Mehmet Gökkaya is an immunology group leader with nine years of experience building clinically actionable immune biomarker models for allergies and infectious diseases, most recently transitioning from a junior group leader role at Helmholtz Munich to lead a prevention-through-prediction group at Universitätsklinikum Augsburg. He combines hands-on expertise in flow cytometry, cell sorting and bioinformatics with a PhD from TUM and a Diplom in Biochemistry to translate nasal and systemic immune signatures into interpretable, transferable diagnostics. Mehmet has authored papers in high-impact journals including Lancet and JACI, holds an IP and a PI grant, and directs flow cytometry services to elevate experimental design across teams. Notably, he drives explainable biomarker modeling—bridging discovery-phase assays with clinical interpretability—and has a track record of international collaborations and rapid tech transfer, exemplified by a short-term translational stint developing a recombinant diagnostic kit.
9 years of coding experience
Diplom Biochemistry, Diplom Biochemistry at University of Tübingen
Doctor of Philosophy - PhD Immunology and Allergy, Doctor of Philosophy - PhD Immunology and Allergy at Technical University of Munich